Literature DB >> 15325726

Analysis of products suspected of containing Aristolochia or Asarum species.

B T Schaneberg1, I A Khan.   

Abstract

Aristolochia species have been administered by those trained in traditional Chinese medicine (TCM) for centuries. After determining Aristolochia fangchi was an adulterant that caused death due to renal failure in a number of patients at a Belgian weight loss clinic, many countries took steps to regulate products containing Aristolochia fangchi as well as other Aristolochia species. The US FDA issued a Consumer Advisory 'advising consumers to stop using any products that may likely contain aristolochic acid'. The Aristolochia and Asarum genera both have been found to contain aristolochic acids. A number of websites have been found from which individuals can order products containing either Aristolochia or Asarum as an ingredient through US merchants. We purchased 25 products from such sites and analyzed them for the presence of aristolochic acid I and II by HPLC with PDA. Six of the products contained detectable amounts of I and II.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325726     DOI: 10.1016/j.jep.2004.06.010

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Prevalence of self-treatment with complementary products and therapies for weight loss: A randomized, cross-sectional Study in Overweight and Obese Patients in Colombia.

Authors:  Pedro Amariles; Laura I González; Nubia A Giraldo
Journal:  Curr Ther Res Clin Exp       Date:  2006-01

Review 2.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

3.  Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns.

Authors:  Megan L Coghlan; James Haile; Jayne Houston; Dáithí C Murray; Nicole E White; Paula Moolhuijzen; Matthew I Bellgard; Michael Bunce
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

Review 4.  Pharmacological overview of galactogogues.

Authors:  Felipe Penagos Tabares; Juliana V Bedoya Jaramillo; Zulma Tatiana Ruiz-Cortés
Journal:  Vet Med Int       Date:  2014-08-31

5.  Metabolomic analysis of complex chinese remedies: examples of induced nephrotoxicity in the mouse from a series of remedies containing aristolochic Acid.

Authors:  Dong-Ming Tsai; Jaw-Jou Kang; Shoei-Sheng Lee; San-Yuan Wang; I-Lin Tsai; Guan-Yuan Chen; Hsiao-Wei Liao; Li Wei-Chu; Ching-Hua Kuo; Y Jane Tseng
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-31       Impact factor: 2.629

6.  Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003.

Authors:  Shu-Ching Hsieh; I-Hsin Lin; Wei-Lum Tseng; Chang-Hsing Lee; Jung-Der Wang
Journal:  Chin Med       Date:  2008-10-23       Impact factor: 5.455

7.  DNA methods for identification of Chinese medicinal materials.

Authors:  Pui Ying Yip; Chi Fai Chau; Chun Yin Mak; Hoi Shan Kwan
Journal:  Chin Med       Date:  2007-09-05       Impact factor: 5.455

8.  Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM).

Authors:  Megan L Coghlan; Garth Maker; Elly Crighton; James Haile; Dáithí C Murray; Nicole E White; Roger W Byard; Matthew I Bellgard; Ian Mullaney; Robert Trengove; Richard J N Allcock; Christine Nash; Claire Hoban; Kevin Jarrett; Ross Edwards; Ian F Musgrave; Michael Bunce
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

9.  Vitamin E (α‑tocopherol) ameliorates aristolochic acid‑induced renal tubular epithelial cell death by attenuating oxidative stress and caspase‑3 activation.

Authors:  Tsai-Kun Wu; Ying-Ru Pan; Hsueh-Fang Wang; Chyou-Wei Wei; Yung-Luen Yu
Journal:  Mol Med Rep       Date:  2017-10-27       Impact factor: 2.952

10.  New Contributions to Asarum Powder on Immunology Related Toxicity Effects in Lung.

Authors:  Yamin Li; Lintao Han; Chunhua Huang; Wangqiang Dai; Guangyu Tian; Fang Huang; Jingjing Li; Jinwei Liu; Qiong Wang; Zhenxiang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.